Lisata Therapeutics, Inc. (LSTA)Healthcare | Biotechnology | Basking Ridge, United States | NasdaqCM
3.23 USD
-0.14
(-4.154%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 3.39 +0.16 (4.842%) ⇧ (April 17, 2026, 4:56 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:32 p.m. EDT
LSTA is currently experiencing a period of high volatility due to the pending acquisition by Kuva Labs Inc., which is offering $5.00 per share plus a $1.00 contingent value right (CVR). The stock has been trading near the 52-week low of $1.81, but recent news indicates that the acquisition is advancing, leading to a 20% increase in the stock price. However, the fundamental data is weak, with negative earnings, negative return on assets, and negative operating margins. The stock is not a good candidate for long-term investment due to its poor fundamentals and lack of dividend history. Short-term traders may consider the acquisition as a potential buying opportunity, but the forecasting model indicates a slight negative trend in the short term. Overall, this stock is risky and should be approached with caution. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.054536 |
| AutoETS | 0.064155 |
| MSTL | 0.065801 |
| AutoARIMA | 1.573204 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 5% |
| H-stat | 12.44 |
| Ljung-Box p | 0.006 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 10.85 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Revenue per Share | 0.02 |
| Market Cap | 29,174,304 |
| Forward P/E | -4.89 |
| Beta | 1.11 |
| Previous Name | Caladrius Biosciences, Inc. |
| Website | https://www.lisata.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.41666663 |
| Address1 | 110 Allen Road |
| Address2 | 2nd Floor |
| All Time High | 637,500.0 |
| All Time Low | 1.81 |
| Ask | 3.28 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 127,070 |
| Average Daily Volume3 Month | 184,790 |
| Average Volume | 184,790 |
| Average Volume10Days | 127,070 |
| Beta | 1.109 |
| Bid | 3.19 |
| Bid Size | 1 |
| Book Value | 1.682 |
| City | Basking Ridge |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.23 |
| Current Ratio | 5.765 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.4095 |
| Day Low | 3.15 |
| Display Name | Lisata Therapeutics |
| Earnings Call Timestamp End | 1,762,464,600 |
| Earnings Call Timestamp Start | 1,762,464,600 |
| Earnings Timestamp | 1,772,139,600 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -18,063,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.718 |
| Enterprise To Revenue | 76.261 |
| Enterprise Value | 12,964,300 |
| Eps Current Year | -0.96 |
| Eps Forward | -0.66 |
| Eps Trailing Twelve Months | -1.91 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.6732 |
| Fifty Day Average Change | -1.4432001 |
| Fifty Day Average Change Percent | -0.3088248 |
| Fifty Two Week Change Percent | 41.666664 |
| Fifty Two Week High | 5.07 |
| Fifty Two Week High Change | -1.8400002 |
| Fifty Two Week High Change Percent | -0.36291915 |
| Fifty Two Week Low | 1.81 |
| Fifty Two Week Low Change | 1.4200001 |
| Fifty Two Week Low Change Percent | 0.78453046 |
| Fifty Two Week Range | 1.81 - 5.07 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 920,298,600,000 |
| Float Shares | 7,275,781 |
| Forward Eps | -0.66 |
| Forward P E | -4.893939 |
| Free Cashflow | -10,854,625 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 21 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 170,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.19214001 |
| Held Percent Institutions | 0.07863 |
| Implied Shares Outstanding | 9,032,292 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,663,200,000 |
| Last Split Factor | 1:15 |
| Long Business Summary | Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. |
| Long Name | Lisata Therapeutics, Inc. |
| Market | us_market |
| Market Cap | 29,174,304 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_338272 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -16,586,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 29,174,299 |
| Number Of Analyst Opinions | 2 |
| Open | 3.15 |
| Operating Cashflow | -15,949,000 |
| Operating Margins | -30.79 |
| Payout Ratio | 0.0 |
| Peg Ratio | 118.4 |
| Phone | 908 842 0100 |
| Post Market Change | 0.15639997 |
| Post Market Change Percent | 4.842104 |
| Post Market Price | 3.3864 |
| Post Market Time | 1,776,459,393 |
| Prev Name | Caladrius Biosciences, Inc. |
| Previous Close | 3.37 |
| Price Eps Current Year | -3.3645835 |
| Price Hint | 4 |
| Price To Book | 1.9203329 |
| Price To Sales Trailing12 Months | 171.61356 |
| Profit Margins | 0.0 |
| Quick Ratio | 5.424 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.14 |
| Regular Market Change Percent | -4.1543 |
| Regular Market Day High | 3.4095 |
| Regular Market Day Low | 3.15 |
| Regular Market Day Range | 3.15 - 3.4095 |
| Regular Market Open | 3.15 |
| Regular Market Previous Close | 3.37 |
| Regular Market Price | 3.23 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 107,441 |
| Return On Assets | -0.43153 |
| Return On Equity | -0.75531995 |
| Revenue Growth | -0.9 |
| Revenue Per Share | 0.02 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 9,032,291 |
| Shares Percent Shares Out | 0.0019 |
| Shares Short | 16,935 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 15,304 |
| Short Name | Lisata Therapeutics, Inc. |
| Short Percent Of Float | 0.0022 |
| Short Ratio | 0.35 |
| Source Interval | 15 |
| State | NJ |
| Symbol | LSTA |
| Target High Price | 15.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 9.5 |
| Target Median Price | 9.5 |
| Total Cash | 15,956,000 |
| Total Cash Per Share | 1.767 |
| Total Debt | 0 |
| Total Revenue | 170,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.91 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.03475 |
| Two Hundred Day Average Change | 0.19525003 |
| Two Hundred Day Average Change Percent | 0.064338095 |
| Type Disp | Equity |
| Volume | 107,441 |
| Website | https://www.lisata.com |
| Zip | 7,920 |